Cellular targets to overcome KRAS inhibitor resistance in pancreatic tumors identified

A study led by University of Cincinnati Cancer Center researchers sheds new light on how pancreatic cancer cells resist treatment and points to potential new combination therapies to make treatments more effective.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup